Clinical Trials in Philadelphia

Showing 4821-4840 of 20,904 trials

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438

This study will evaluate efficacy and safety of GSK1070806 in moderate to severe atopic dermatitis (AtD) participants.

GlaxoSmithKline34 participantsStarted Nov 2021

North Little Rock, Arkansas, United States • Miami, Florida, United States • Tampa, Florida, United States +8 more locations

COMPLETEDPhase 3< 1 mile

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

NCT04209855

This Phase 3 study is designed to compare the efficacy and safety of mirvetuximab soravtansine (MIRV) vs. IC chemotherapy in participants with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, whose tumors express a high-level of FRα. Participants will be, in the opinion of the Investigator, appropriate for single-agent therapy for their next line of therapy. The FRα positivity will be defined by the Ventana FOLR1 (FOLR1-2.1) CDx assay.

Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer

AbbVie453 participantsStarted Dec 2019

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +211 more locations

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

Find Trials by Condition in Philadelphia

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

A Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of Chronic Obstructive Pulmonary Disease (COPD) Patients Who Initiate Breztri and Multiple Inhaler Triple Therapy (MITT) in the United States (US)

MarginProbe 2.0 Data Collection Protocol

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

A Pilot Randomized Controlled Trial for Hand Osteoarthritis

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis

Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Symptom Management Implementation of Patient Reported Outcomes in Oncology

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis